"Liver" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
Descriptor ID |
D008099
|
MeSH Number(s) |
A03.620
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Liver".
Below are MeSH descriptors whose meaning is more specific than "Liver".
This graph shows the total number of publications written about "Liver" by people in this website by year, and whether "Liver" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 2 | 3 |
1995 | 3 | 1 | 4 |
1996 | 3 | 2 | 5 |
1997 | 4 | 1 | 5 |
1998 | 4 | 6 | 10 |
1999 | 1 | 6 | 7 |
2000 | 3 | 2 | 5 |
2001 | 2 | 1 | 3 |
2002 | 1 | 1 | 2 |
2003 | 5 | 4 | 9 |
2004 | 1 | 5 | 6 |
2005 | 6 | 6 | 12 |
2006 | 5 | 3 | 8 |
2007 | 2 | 6 | 8 |
2008 | 5 | 2 | 7 |
2009 | 4 | 7 | 11 |
2010 | 3 | 11 | 14 |
2011 | 4 | 9 | 13 |
2012 | 6 | 6 | 12 |
2013 | 4 | 5 | 9 |
2014 | 9 | 5 | 14 |
2015 | 6 | 1 | 7 |
2016 | 4 | 8 | 12 |
2017 | 7 | 5 | 12 |
2018 | 9 | 6 | 15 |
2019 | 5 | 6 | 11 |
2020 | 2 | 7 | 9 |
2021 | 6 | 8 | 14 |
2022 | 1 | 8 | 9 |
2023 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver" by people in Profiles.
-
Deletion of hepatocyte cysteine dioxygenase type 1, a bile acid repressed gene, enhances glutathione synthesis and ameliorates acetaminophen hepatotoxicity. Biochem Pharmacol. 2024 Apr; 222:116103.
-
Establishment and characterization of turtle liver organoids provides a potential model to decode their unique adaptations. Commun Biol. 2024 Feb 22; 7(1):218.
-
Endotoxin biomarkers, hepatic fat fraction, liver volume and liver stiffness among adolescents at high-risk for non-alcoholic fatty liver disease: The HEROES study. Pediatr Obes. 2024 Feb; 19(2):e13091.
-
Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis. Mol Cancer Res. 2023 Sep 01; 21(9):933-946.
-
Using IV-Tubing "Bridge" from Splenic Artery to Superior Mesentery Artery to Create a Single Arterial Cannulation for Normothermic Machine Perfusion When Donor Liver Has Replaced Right Hepatic Artery. Am J Case Rep. 2023 Jul 16; 24:e940437.
-
Bile acids as metabolic regulators: an update. Curr Opin Gastroenterol. 2023 05 01; 39(3):249-255.
-
Postprandial triglycerides and fibroblast growth factor 19 as potential screening tools for paediatric non-alcoholic fatty liver disease. Pediatr Obes. 2023 04; 18(4):e13007.
-
Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice. J Lipid Res. 2023 03; 64(3):100340.
-
17a-estradiol, a lifespan-extending compound, attenuates liver fibrosis by modulating collagen turnover rates in male mice. Am J Physiol Endocrinol Metab. 2023 02 01; 324(2):E120-E134.
-
TFEB regulates sulfur amino acid and coenzyme A metabolism to support hepatic metabolic adaptation and redox homeostasis. Nat Commun. 2022 09 28; 13(1):5696.